Health
Medicine to prevent patients from developing COVID-19 tested in UK – TASS
Scientists hope that people wouls be protected from COVID-19 for a period of between six months and one year
LONDON, December 26. /TASS/. A medicine that can potentially prevent people exposed to novel coronavirus from developing COVID-19 is now being tested in the United Kingdom, the Guardian reported on its website Friday.
The medicine, based on monoclonal antibodies created in a laboratory, was developed by UK-Swedish pharmaceutical company AstraZeneca and the University College London Hospitals.
“If we can prove that this treatment works and prevent people who are exposed to the virus going on to develop…
-
Noosa News23 hours agoBrisbane doctor jailed for trafficking ‘breathtaking amount’ of drugs
-
Noosa News16 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
Business14 hours ago10 ASX shares to buy after the market selloff
-
General18 hours ago‘We are here for you’: PM to bring help to flood zones